Evidence map›Paper›PMID 34905121›Full record

ArticleEJNMMI research2021

First experiences with

Thomas J W Klein Nulent, Robert J J van Es, Stefan M Willems, Arthur J A T Braat, Lot A Devriese, Remco de Bree, Bart de Keizer

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Clinical Characteristics Associated with High [Nuclear medicine and molecular imaging · 2026
    Article
  2. Incidental detection of PDAC viaFrontiers in nuclear medicine · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Advances in Radioligand Theranostics in Oncology.Molecular diagnosis & therapy · 2024
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Diagnostic Accuracy of [Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  15. RadioLigand Therapy with [Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  16. PSMA-Directed Imaging and Therapy of Salivary Gland Tumors: A Single-Center Retrospective Study.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  17. Article
  18. Review
  19. The Therapeutic Landscape of Salivary Gland Malignancies-Where Are We Now?International journal of molecular sciences · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Thomas J W Klein NulentDepartment of Head and Neck Surgical Oncology, University Medical Center Utrecht, P.O. Box 85500, Heidelberglaan 100, 3508 GA, Utrecht, The Netherlands. t.j.w.kleinnulent@umcutrecht.nl.ORCID http://orcid.org/0000-0003-3597-4334
Robert J J van EsDepartment of Head and Neck Surgical Oncology, University Medical Center Utrecht, P.O. Box 85500, Heidelberglaan 100, 3508 GA, Utrecht, The Netherlands.
Stefan M WillemsDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Arthur J A T BraatDepartment of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Lot A DevrieseDepartment of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Remco de BreeDepartment of Head and Neck Surgical Oncology, University Medical Center Utrecht, P.O. Box 85500, Heidelberglaan 100, 3508 GA, Utrecht, The Netherlands.
Bart de KeizerDepartment of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
University Medical Center Utrecht · NLHeidelberg University · DEUniversity Medical Center Groningen · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdvanced salivary gland cancers become difficult to treat when they are technically irresectable and radiotherapy limits are exceeded. There is also an unmet need to improve palliative systemic therapy. Salivary glands depict the Prostate-Specific Membrane Antigen (PSMA) on

methodsThis study aimed to retrospectively evaluate the effectiveness of

resultsSix patients were treated with

conclusionsPalliative

Indexed as

Adenoid cystic carcinomaLutetiumPositron-emission tomographyRadionuclideSalivary gland cancer

Identifiers

PMID34905121
PMCPMC8671577
OpenAlexW4200059278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.